The new face of fighting cancer

The battle against cancer has raged for decades and the end game is nearing. Merus’ innovative bispecific antibody therapeutics referred to as Biclonics® are designed to recruit the immune system to kill cancer cells and tip the balance in favor of patients with more effective treatments that have less side effects. Ultimately, it is Merus’ goal to help declare victory for patients with this devastating disease to help them lead normal lives.